Edwards, J. and Powel, A. (2019) Combined colorectal cancer array. [Data Collection]
Related Enlighten Publications
- Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer
- Colorectal cancer subtypes: Translation to routine clinical pathology
- The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer
- ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer
- Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer
- Signal transduction and activator of transcription-3 (STAT3) in patients with colorectal cancer: associations with the phenotypic features of the tumour and host
- Reply to comment of "ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer"
- A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with stage II/III colorectal cancer
- The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer
Collection description
This database was established to allow us to investigate biomarkers in colorectal cancer.
Safehaven number: GSH/18/ON007
Contains 1030 patients who had undergone a potentially curative resection for stage I-IV CRC between 1997 and 2007 at the Glasgow Royal Infirmary, Western Infirmary or Stobhill Hospitals (Glasgow, UK). Resection was considered curative based on pre-operative computed tomography and intra-operative findings. Tumours were staged using the fifth edition of the AJCC/UICC-TNM staging system. The presence of venous invasion was assessed using elastica staining and Ki67 proliferation index was previously established in this cohort. Tumour differentiation, graded as well/moderate or poor in accordance with Royal College of Pathologists and additional data were taken from pathology reports issued following resection. Following surgery, patients with stage III or high-risk stage II disease and without significant co-morbid disease precluding adjuvant treatment were considered for 5-fluorouracil-based chemotherapy. Patients were followed up for at least five years and date and cause of death were crosschecked with the cancer registration system and the Registrar General (Scotland). Cancer-specific survival (CSS) was measured from date of surgery until date of death from CRC.
| College / School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
|---|---|
| Date Deposited: | 15 Apr 2019 11:19 |
| URI: | https://researchdata.gla.ac.uk/id/eprint/783 |
Available Files
There are no files for this dataset available to download.
Repository Staff Only: Update this record